IN154918B - - Google Patents

Info

Publication number
IN154918B
IN154918B IN736/DEL/80A IN736DE1980A IN154918B IN 154918 B IN154918 B IN 154918B IN 736DE1980 A IN736DE1980 A IN 736DE1980A IN 154918 B IN154918 B IN 154918B
Authority
IN
India
Application number
IN736/DEL/80A
Other languages
English (en)
Inventor
Michael Stephen Kellogg
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IN726/DEL/83A priority Critical patent/IN154767B/en
Publication of IN154918B publication Critical patent/IN154918B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • C07D499/08Modification of a carboxyl radical directly attached in position 2, e.g. esterification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/74Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with carbocyclic rings directly attached to the carboxamido radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
IN736/DEL/80A 1979-10-22 1980-10-08 IN154918B (en:Method)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN726/DEL/83A IN154767B (en:Method) 1979-10-22 1983-10-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/086,864 US4287181A (en) 1979-10-22 1979-10-22 Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors

Publications (1)

Publication Number Publication Date
IN154918B true IN154918B (en:Method) 1984-12-22

Family

ID=22201393

Family Applications (1)

Application Number Title Priority Date Filing Date
IN736/DEL/80A IN154918B (en:Method) 1979-10-22 1980-10-08

Country Status (38)

Country Link
US (1) US4287181A (en:Method)
JP (2) JPS5665892A (en:Method)
KR (1) KR840000797B1 (en:Method)
AR (1) AR227164A1 (en:Method)
AT (2) AT369372B (en:Method)
AU (1) AU519578B2 (en:Method)
BE (1) BE885812A (en:Method)
BG (2) BG35189A3 (en:Method)
CA (2) CA1144159A (en:Method)
CH (2) CH646175A5 (en:Method)
CS (2) CS219291B2 (en:Method)
DD (1) DD154542A5 (en:Method)
DE (1) DE3039504C2 (en:Method)
DK (1) DK389480A (en:Method)
ES (1) ES496166A0 (en:Method)
FI (1) FI71156C (en:Method)
FR (1) FR2467852A1 (en:Method)
GB (3) GB2061930B (en:Method)
GR (1) GR70714B (en:Method)
GT (1) GT198065892A (en:Method)
HU (1) HU183236B (en:Method)
IE (3) IE51027B1 (en:Method)
IL (1) IL61307A (en:Method)
IN (1) IN154918B (en:Method)
IT (1) IT1149259B (en:Method)
LU (1) LU82880A1 (en:Method)
MX (1) MX6094E (en:Method)
NL (1) NL183358C (en:Method)
NO (1) NO159019C (en:Method)
NZ (1) NZ195307A (en:Method)
PH (5) PH16219A (en:Method)
PL (2) PL129534B1 (en:Method)
PT (1) PT71946B (en:Method)
RO (2) RO81225B (en:Method)
SE (1) SE451455B (en:Method)
SU (2) SU1122227A3 (en:Method)
YU (2) YU41743B (en:Method)
ZA (1) ZA806452B (en:Method)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use
US4444687A (en) * 1981-06-08 1984-04-24 Bristol-Myers Company 2β-Chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone methylene diol mixed esters
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
US4351840A (en) * 1981-09-18 1982-09-28 Pfizer Inc. Antibacterial esters of resorcinol with ampicillin and penicillanic acid 1,1-dioxide derivatives
JPS58109490A (ja) * 1981-12-21 1983-06-29 Sankyo Co Ltd ペニシリン誘導体
US4452796A (en) * 1982-06-14 1984-06-05 Pfizer Inc. 6-Aminoalkylpenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4427678A (en) 1982-01-11 1984-01-24 Pfizer Inc. 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
RO87705A (ro) * 1982-01-11 1985-10-31 Pfizer Inc,Us Procedeu pentru prepararea unor derivati ai acidului 6-aminoalchilpenicilanic 1,1-dioxid
US4377590A (en) * 1982-05-10 1983-03-22 Pfizer Inc. Derivatives of ampicillin and amoxicillin with beta-lactamase inhibitors
US4588527A (en) * 1983-06-06 1986-05-13 Pfizer Inc. Process for preparing penicillanic acid 1,1-dioxide derivatives
US4499017A (en) * 1983-06-06 1985-02-12 Pfizer Inc. Beta-lactamase inhibiting 6-(alkoxyamino-methyl) penicillanic acid 1,1-dioxide and derivatives
US4502990A (en) * 1983-06-06 1985-03-05 Pfizer Inc. Process for 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives thereof
US4536393A (en) * 1983-06-06 1985-08-20 Pfizer Inc. 6-(Aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
ES8604972A1 (es) * 1984-01-30 1986-02-16 Pfizer Un procedimiento para la preparacion de acidos 6-metilen-(sustituido) penicilanicos y derivados de los mismos.
US4826833A (en) * 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
US5015473A (en) * 1984-01-30 1991-05-14 Pfizer Inc. 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
US4503040A (en) * 1984-02-27 1985-03-05 Pfizer Inc. 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
US4847247A (en) * 1984-07-30 1989-07-11 Merck & Co., Inc. Penicillin derivatives as anti-inflammatory and antidegenerative agents
US4590073A (en) * 1984-10-22 1986-05-20 Pfizer Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
US4591459A (en) * 1984-12-03 1986-05-27 Pfizer Inc. Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides
US4762921A (en) * 1985-04-18 1988-08-09 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4613462A (en) * 1985-07-02 1986-09-23 Pfizer, Inc. 6-substituted penicillanic acid 1,1-dioxide compounds
ATE74359T1 (de) * 1987-01-27 1992-04-15 Pfizer 6-beta(substituierte)-(s)hydroxymethylpenicillans|ure und deren derivate.
US4782050A (en) * 1987-01-27 1988-11-01 Pfizer Inc. 6-beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
JP2006526612A (ja) * 2003-06-05 2006-11-24 ファイザー・プロダクツ・インク ベータ−ラクタマーゼ阻害剤・プロドラッグ
ES2398258T3 (es) * 2007-03-09 2013-03-14 Otsuka Chemical Co., Ltd. Procedimiento para producir un compuesto 6-hidroxieltil penam
CN109422765B (zh) * 2017-09-05 2020-08-28 香港理工大学深圳研究院 C类β-内酰胺酶抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (en:Method) * 1973-04-04 1982-10-22
US4207323A (en) * 1975-11-21 1980-06-10 Merck & Co., Inc. 6-Substituted methyl penicillins, derivatives and analogues thereof
US4053468A (en) * 1976-02-25 1977-10-11 Smithkline Corporation Process for preparing 7-oxo cephalosporins and 6-oxo penicillins
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4123539A (en) * 1977-12-29 1978-10-31 Merck & Co., Inc. 6-Ethylpenicillanic acid
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
JPS5598186A (en) * 1979-01-10 1980-07-25 Beecham Group Ltd Manufacture of penicillin derivative
GB2076812A (en) * 1980-05-22 1981-12-09 Ciba Geigy Ag Penam-dioxide compounds, processes for their manufacture, and their use

Also Published As

Publication number Publication date
PL129534B1 (en) 1984-05-31
PH16219A (en) 1983-08-09
IL61307A (en) 1984-03-30
BG35189A3 (en) 1984-02-15
BE885812A (fr) 1981-04-21
PL227420A1 (en:Method) 1982-08-30
GB2129421B (en) 1984-11-14
FI803311L (fi) 1981-04-23
YU267680A (en) 1983-09-30
HU183236B (en) 1984-04-28
GR70714B (en:Method) 1983-01-18
AU6354880A (en) 1981-04-30
NO159019B (no) 1988-08-15
IL61307A0 (en) 1980-12-31
RO81225B (ro) 1983-02-28
CH647242A5 (fr) 1985-01-15
NL183358B (nl) 1988-05-02
CA1144159A (en) 1983-04-05
GB2128986A (en) 1984-05-10
DE3039504A1 (de) 1981-04-30
GB2061930B (en) 1984-06-13
IE850293L (en) 1981-04-22
FI71156C (fi) 1986-11-24
PT71946A (en) 1980-11-01
IE852229L (en) 1981-04-22
CS219291B2 (en) 1983-03-25
PH18316A (en) 1985-05-29
PL235907A1 (en:Method) 1982-09-13
FR2467852B1 (en:Method) 1983-10-07
RO86176B (ro) 1985-03-31
PT71946B (en) 1981-08-31
IE51027B1 (en) 1986-09-17
RO81225A (ro) 1983-02-15
NL183358C (nl) 1988-10-03
NO159019C (no) 1988-11-23
BG38639A3 (en) 1986-01-15
MX6094E (es) 1984-11-12
AU519578B2 (en) 1981-12-10
GB2129421A (en) 1984-05-16
SU1122227A3 (ru) 1984-10-30
LU82880A1 (fr) 1981-06-04
IE802174L (en) 1981-04-22
PH17458A (en) 1984-08-29
SE8007354L (sv) 1981-04-23
IT8025488A0 (it) 1980-10-21
ES8204437A1 (es) 1982-05-01
DE3039504C2 (de) 1984-10-11
PL129638B1 (en) 1984-05-31
JPS6135197B2 (en:Method) 1986-08-12
PH17317A (en) 1984-07-20
PH17315A (en) 1984-07-20
SU1026654A3 (ru) 1983-06-30
ES496166A0 (es) 1982-05-01
JPS61178988A (ja) 1986-08-11
SE451455B (sv) 1987-10-12
KR840000797B1 (ko) 1984-06-12
AT374479B (de) 1984-04-25
CA1163924A (en) 1984-03-20
ATA10882A (de) 1983-09-15
YU42075B (en) 1988-04-30
GB2128986B (en) 1985-06-19
FI71156B (fi) 1986-08-14
CS219292B2 (en) 1983-03-25
CH646175A5 (fr) 1984-11-15
ATA518580A (de) 1982-05-15
YU67183A (en) 1984-02-29
KR830004309A (ko) 1983-07-09
NO803136L (no) 1981-04-23
RO86176A (ro) 1985-03-15
NL8005810A (nl) 1981-04-24
US4287181A (en) 1981-09-01
IE51028B1 (en) 1986-09-17
DK389480A (da) 1981-04-23
FR2467852A1 (fr) 1981-04-30
GB8316829D0 (en) 1983-07-27
IE51026B1 (en) 1986-09-17
GB2061930A (en) 1981-05-20
AT369372B (de) 1982-12-27
IT1149259B (it) 1986-12-03
GB8316830D0 (en) 1983-07-27
JPS5665892A (en) 1981-06-03
NZ195307A (en) 1984-08-24
ZA806452B (en) 1981-10-28
AR227164A1 (es) 1982-09-30
YU41743B (en) 1987-12-31
GT198065892A (es) 1982-04-10
DD154542A5 (de) 1982-03-31

Similar Documents

Publication Publication Date Title
FR2447611B1 (en:Method)
FR2467852B1 (en:Method)
BR8002583A (en:Method)
BR8006808A (en:Method)
FR2446474B1 (en:Method)
FR2449026B1 (en:Method)
FR2449143B3 (en:Method)
FR2445948B2 (en:Method)
FR2446410B3 (en:Method)
FR2447452B1 (en:Method)
AU79557S (en:Method)
AU78390S (en:Method)
AU79950S (en:Method)
AU77669S (en:Method)
AU80228S (en:Method)
AU77763S (en:Method)
AU78270S (en:Method)
AU78271S (en:Method)
AU79918S (en:Method)
AU79826S (en:Method)
AU79559S (en:Method)
AU79558S (en:Method)
BR5901094U (en:Method)
AU79200S (en:Method)
AU78385S (en:Method)